Menu
This security has been delisted
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Search results

Why the Market Dipped But Adma Biologics (ADMA) Gained Today
Why the Market Dipped But Adma Biologics (ADMA) Gained Today

In the latest trading session, Adma Biologics (ADMA) closed at $15.15, marking a +1.03% move from the previous day. The stock outperformed the S&P 500, which registered a daily loss of 0.61%

Adma Biologics (ADMA) Advances While Market Declines: Some Information for Investors
Adma Biologics (ADMA) Advances While Market Declines: Some Information for Investors

Adma Biologics (ADMA) ended the recent trading session at $15.02, demonstrating a +1.01% change from the preceding day's closing price. The stock's change was more than the S&P 500's daily loss of

Adma Biologics (ADMA) Registers a Bigger Fall Than the Market: Important Facts to Note
Adma Biologics (ADMA) Registers a Bigger Fall Than the Market: Important Facts to Note

Adma Biologics (ADMA) ended the recent trading session at $14.99, demonstrating a -4.34% change from the preceding day's closing price. The stock's change was less than the S&P 500's daily loss of

Zacks Industry Outlook Highlights Terns Pharmaceuticals, ADMA Biologics, ANI Pharmaceuticals and Liquidia
Zacks Industry Outlook Highlights Terns Pharmaceuticals, ADMA Biologics, ANI Pharmaceuticals and Liquidia

For Immediate Release

Chicago, IL – March 16, 2026 – Today, Zacks Equity Research discusses Terns Pharmaceuticals TERN, ADMA Biologics ADMA, ANI Pharmaceuticals ANIP and Liquidia Corp. LQDA.

Wall Street Bulls Look Optimistic About Adma Biologics (ADMA): Should You Buy?
Wall Street Bulls Look Optimistic About Adma Biologics (ADMA): Should You Buy?

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)

Best Momentum Stocks to Buy for March 12th
Best Momentum Stocks to Buy for March 12th

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, March 12:

ADMA Biologics, Inc. ADMA: This biopharmaceutical company has a Zacks Rank #1 and

Gensight Biologics SA

WKN: A2ANGZ / Name: Gensight / Stock / Biotechnology & Medical Research / Micro Cap /

?
-7.260%

Cansino Biologics Inc.

WKN: A2PGFW / Name: Cansino Biologics Inc. / Stock / ? /

?
-3.140%

Mustgrow Biologics Corp.

WKN: A2PNS7 / Name: Mustgrow Biologics Corp. / Stock / ? /

?
1.990%

Pure Biologics S.a.

WKN: A2N9NP / Name: Pure Biologics S.a. / Stock / ? /

?
-7.460%

Innovent Biologics, Inc.

WKN: A2N7N8 / Name: Innovent Biologics / Stock / Small Cap /

?
-3.450%

Abcellera Biologics Inc.

WKN: A2QKXS / Name: Abcellera Biologics Inc. / Stock / ? /

€2.90
-2.260%

Heat Biologics Inc.

WKN: A2QJR8 / Symbol: HBTX / Name: Heat Biologics / Stock / Biotechnology & Medical Research / Micro Cap /

€0.069
-24.860%

Wuxi Biologics Cayman Inc.

WKN: A2QJCN / Name: Wuxi Biologics / Stock / Mid Cap /

€3.56
-3.310%

Wuxi Biologics (cayman) Inc.

WKN: A2PQ3Q / Name: Wuxi Biologics (cayman) Inc. / Stock / ? /

?
-4.140%

Synthetic Biologics Inc.

WKN: A3DMG6 / Symbol: SYN / Name: Synthetic Biologics / Stock / Biotechnology & Medical Research / Small Cap /

€0.12
-0.680%

Fibrobiologics Inc.

WKN: A3EP67 / Name: Fibrobiologics Inc. / Stock / ? /

?
-8.180%

Theriva Biologics Inc.

WKN: A40MGC / Name: Theriva Biologics Inc. / Stock / ? /

€2.42
-